Moschip Technologies Q2 FY27 Results: Consolidated Net Loss ₹30.40 Crore on Total Income of ₹120 Crore

Earnings
Semiconductor and engineering services

Blacklitt Research28 October 20263 min read

Moschip Technologies reported a consolidated net loss of ₹30.40 crore for the quarter ended 30 Sep 2026 on total income of ₹119.94 crore, against a net profit of ₹12.04 crore a year earlier, the company said in a filing on 28 Oct 2026. Standalone net loss for the quarter was ₹32.73 crore on total income of ₹99.85 crore.

Key highlights

Consolidated

Including its subsidiaries

Total income: ₹119.94 crore, down 19.0% YoY and up 1.3% QoQ
Net profit: Loss of ₹30.40 crore, against profit of ₹12.04 crore in Q2 FY26
EPS: Basic loss of ₹1.56 per share, against basic earnings of ₹0.63 a year earlier
Finance costs: ₹2.56 crore, up 120.7% YoY and 24.6% QoQ

Standalone

The company on its own, without its subsidiaries

Total income: ₹99.85 crore, down 24.2% YoY and 3.2% QoQ
Net profit: Loss of ₹32.73 crore, against profit of ₹9.63 crore in Q2 FY26
EPS: Basic loss of ₹1.68 per share, against basic earnings of ₹0.51 a year earlier
Finance costs: ₹2.53 crore, up 122.5% YoY and 27.5% QoQ

Summary

Consolidated ₹ crore
Particulars	Q2 FY27	Q2 FY26	YoY	Q1 FY27	QoQ
	119.94	148.14	-19.0%	118.45	+1.3%
Revenue from operations	119.08	146.94	-19.0%	116.21	+2.5%
Other income	0.85	1.19	-28.4%	2.24	-61.8%
	-30.40	12.04	n/a	2.45	n/a
Profit before tax	-28.88	12.48	n/a	3.66	n/a
Finance costs	2.56	1.16	+120.7%	2.06	+24.6%
Depreciation	7.50	4.49	+67.2%	6.08	+23.4%
Tax expense	1.52	0.44	+247.2%	1.21	+25.6%
Net profit margin	-25.35%	8.13%	-33.48 pp	2.07%	-27.41 pp
EPS, basic (₹)	-1.56	0.63	n/a	0.13	n/a

Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

Other income is 0.7% of total income this quarter, so the result rests almost entirely on operations.

The loss before tax of ₹28.88 crore compares with a profit before tax of ₹12.48 crore a year earlier. Depreciation rose 67.2% to ₹7.50 crore and finance costs rose 120.7% to ₹2.56 crore, while tax expense rose to ₹1.52 crore. The filing records additional costs on a high complex turnkey ASIC project, including cost escalations beyond the company's control and costs for scope upgrades requested by the customer, but it does not quantify those costs.

Against the previous quarter, consolidated total income rose 1.3% while the net loss stood at ₹30.40 crore against a profit of ₹2.45 crore. The company says it is in active discussions with the customer for reimbursement of the scope upgrade costs; the outcome of those discussions is not known from the filing.

Standalone ₹ crore
Particulars	Q2 FY27	Q2 FY26	YoY	Q1 FY27	QoQ
	99.85	131.72	-24.2%	103.16	-3.2%
Revenue from operations	99.37	130.50	-23.9%	101.15	-1.8%
Other income	0.48	1.22	-60.5%	2.01	-76.0%
	-32.73	9.63	n/a	0.20	n/a
Profit before tax	-32.73	9.67	n/a	0.20	n/a
Finance costs	2.53	1.14	+122.5%	1.99	+27.5%
Depreciation	6.81	3.87	+76.1%	5.38	+26.6%
Tax expense	0.00	0.04	n/a	0.00	n/a
Net profit margin	-32.78%	7.31%	-40.09 pp	0.19%	-32.97 pp
EPS, basic (₹)	-1.68	0.51	n/a	0.01	n/a

Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

Standalone revenue from operations fell 23.9% YoY and other income fell 60.5%, so the standalone decline in total income is steeper than the consolidated one, which fell 19.0%. Standalone net loss of ₹32.73 crore is ₹2.33 crore wider than the consolidated loss of ₹30.40 crore.

Standalone tax expense was nil in the quarter, against ₹0.04 crore a year earlier, so the loss before tax and the net loss are the same figure.

Inference

The filing records that the board approved the acquisition of 73% of Vayavya Labs Private Limited for ₹266.71 crore, of which ₹154.52 crore is cash and ₹112.19 crore is paid through the issue of 50,50,686 equity shares at ₹222.14 each. The swap shares and the acquisition are subject to shareholder approval at an EGM on 25 Nov 2026 and to regulatory approvals.

The filing says the remaining 27% will be acquired after 31 Mar 2028, with valuation linked to Vayavya's business performance, but it does not say on what basis that valuation will be set. The filing also does not say what the reason for the widening loss is, or how the Vayavya acquisition will affect the results.

Reference: Original filing (PDF)

Sign up to continue reading

Create a free account to read the rest of this article and the analysis that follows.

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.